EMD-70338

Single-particle
4.09 Å
EMD-70338
3D View Gallery
Deposition: 25/04/2025
Map released: 21/01/2026
Last modified: 21/01/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-70338
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9od2 summary report (pdf.gz) Map and 9od2 FULL report (pdf.gz)
EMICSS annotations (xml)

Cryo-EM structure of modified Zika virus E protein dimer complexed with a neutralizing antibody SMZAb2 Fab

EMD-70338

Single-particle
4.09 Å
EMD-70338
3D View Gallery
Deposition: 25/04/2025
Map released: 21/01/2026
Last modified: 21/01/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Zika virus, Homo sapiens
Sample: Zika virus E protein dimer complex with a neutralizing antibody SMZAB2 Fab
Fitted models: 9od2

Deposition Authors: Galkin A, Pozharski E
Rational design of flavivirus E protein vaccine optimizes immunogenicity and mitigates antibody dependent enhancement risk.
Wang Y, Galkin A, Shang X, Marin A, Jin S, Ye TJ, Bale S, Chiang CI, Chowdhury A, Chenine AL, Turonis A, Greenhouse J, Stone R, Wear J, Kar S, Andersen H, Huang YS, Vanlandingham DL, Higgs S, Lapidus RG, Fuerst T, Weber DJ, Wyatt RT, Iffland C, Pierson TC, Andrianov AK, Pozharski E, Li Y
(2025) Nat Commun , 16 , 11558 - 11558
PUBMED: 41429771
DOI: doi:10.1038/s41467-025-67447-4
ISSN: 2041-1723